John S. Montalbano Ab Cellera Biologics Inc. (ABCL) insider trading activity

John S. Montalbano is Director of AbCellera Biologics Inc.. Currently has a direct ownership of 171,000 shares of ABCL, which is worth approximately $395,010. The most recent transaction as insider was on Mar 10, 2025, when has been sold 25,000 shares (Common Shares) at a price of $2.3 per share, resulting in proceeds of $57,499. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 171K

98.84% 3M change

98.84% 12M change

Total Value Held $395,010

John S. Montalbano Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2025	BUY Open market or private purchase	$57,499 $2.3 p/Share	25,000 Added 12.76%	171,000 Common Shares
Mar 06 2025	BUY Open market or private purchase	$140,400 $2.34 p/Share	60,000 Added 29.13%	146,000 Common Shares
Nov 08 2023	BUY Open market or private purchase	$44,600 $4.46 p/Share	10,000 Added 10.42%	86,000 Common Shares
Nov 06 2023	BUY Open market or private purchase	$92,800 $4.64 p/Share	20,000 Added 20.83%	76,000 Common Shares
Mar 04 2022	BUY Open market or private purchase	$85,400 $8.54 p/Share	10,000 Added 15.15%	56,000 Common Shares
Mar 01 2022	BUY Open market or private purchase	$181,000 $9.05 p/Share	20,000 Added 30.3%	46,000 Common Shares
Aug 16 2021	BUY Open market or private purchase	$103,380 $17.23 p/Share	6,000 Added 18.75%	26,000 Common Shares
Dec 15 2020	BUY Open market or private purchase	$400,000 $20.0 p/Share	20,000 Added 50.0%	20,000 Common Shares

JSM

John S. Montalbano

Director

Vancouver, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Value

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

Operation

Value

Type

News

Receive news related to AbCellera Biologics Inc.

Track Activities on ABCL

Account